SAM
TRIL

Sectoral Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Sectoral Asset Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-234,248
Closed -$1.21M – 72
2017
Q3 		$1.21M Buy
234,248
+50,976
+28% +$240K 0.16% 59
2017
Q2 		$806K Buy
183,272
+55,000
+43% +$304K 0.09% 59
2017
Q1 		$789K Buy
128,272
+28,272
+28% +$166K 0.09% 61
2016
Q4 		$565K Buy
+100,000
New +$996K 0.06% 53

Other funds holding TRIL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sectoral Asset Management's TRIL Position: Q4 2017 in Review

Sectoral Asset Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2017, closing a stake of 234,248 shares — an estimated $1.21M sold.

Sectoral Asset Management first reported a position in TRIL in Q4 2016 and held it in 4 quarters. The position peaked at $1.21M in Q3 2017. 26 funds tracked by Wall St. Rank hold TRIL as of Q4 2017.

  • Sectoral Asset Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2017 after selling out during the quarter.
  • Sectoral Asset Management sold 234,248 Trillium Therapeutics Inc. shares in Q4 2017, an estimated $1.21M.
  • Sectoral Asset Management first reported a position in Trillium Therapeutics Inc. in Q4 2016 and held it in 4 quarters.
  • Sectoral Asset Management's Trillium Therapeutics Inc. position peaked at $1.21M in Q3 2017.
  • 26 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2017.

Based on Sectoral Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.